Related Experiment Video

Updated: Sep 25, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

p73 is effective in p53-null pancreatic cancer cells resistant to wild-type TP53 gene replacement

Florian Rödicker1, Brigitte M Pützer

  • 1Centre for Cancer Research and Cancer Therapy, Institute of Molecular Biology, University of Essen, Medical School, D-45122 Essen, Germany.

Cancer Research
|June 5, 2003
PubMed

Insights

Gene therapy using p73 shows promise for pancreatic cancer. Overexpressed p73 induces apoptosis in p53-null cells, offering a potential new treatment strategy for this resistant cancer type.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Pancreatic cancer remains a challenging disease with limited effective treatments.
  • Gene therapy is an emerging approach for cancer treatment.
  • The tumor suppressor proteins p53 and p73 play critical roles in apoptosis and tumor suppression.

Purpose of the Study:

  • To investigate the potential of p73 as a therapeutic agent in pancreatic cancer.
  • To compare the apoptotic effects of p53 and p73 in pancreatic cancer cells.
  • To explore the mechanism of p73-mediated apoptosis in p53-deficient cells.

Main Methods:

  • Adenovirus-mediated gene delivery was used for p53 and p73 overexpression.
  • Apoptosis induction was assessed in various pancreatic cancer cell lines, including p53-negative AsPC-1 cells.
  • The expression of the proapoptotic target gene P53AIP1 and p53 phosphorylation at Ser-46 were analyzed.

Main Results:

  • Adenovirus-mediated p73 overexpression strongly induced apoptosis in pancreatic cancer cells.
  • The apoptotic effect of p53 varied, with p53-negative AsPC-1 cells showing resistance to p53-mediated apoptosis.
  • Ectopically expressed p73, but not wild-type p53, activated P53AIP1 in AsPC-1 cells, independent of p53 phosphorylation at Ser-46.

Conclusions:

  • p73 demonstrates significant potential as an anticancer therapeutic agent for pancreatic ductal adenocarcinoma.
  • p73 can overcome resistance to wild-type TP53 gene replacement therapy in p53-null pancreatic cancer.
  • Targeting p73 offers a promising strategy for treating p53-deficient pancreatic cancers.

More Related Videos

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...